Pfizer Inc. (PFE) Stock Grade

About Pfizer Inc.'s fundamentals

Pfizer is a large-cap pharmaceutical company with a market capitalization of $163.7 billion, currently trading at a P/E ratio of 18.2. The company is experiencing a contraction in revenues, which declined 1.7% year-over-year, though it maintains a solid net profit margin of 12.4%, indicating efficient cost management on its existing sales base. Return on equity stands at 9.0%, suggesting modest returns on shareholder capital, while the company offers a notably high dividend yield of 6.9%, which reflects its commitment to returning capital to investors.